Clinical Trials Browser

Phase EARLY_PHASE1 × durvalumab × Gastrointestinal × Clear all

NCT06824363 2026-01-30

ProofPrincip IntraTu TCells SinglDoseImmunCheckpoinInhib Gastro-Esophage Adenocarcinoma w/ARID1a Mu

Phase EARLY_PHASE1 Not yet recruiting

Gastrointestinal

Adenocarcinoma Of Esophagus